Eye health improvement program for seniors in Shanghai
Official title: Shanghai Eye Study for Adults
Run by Shanghai Eye Disease Prevention and Treatment Center · NCT03455478 · Data updated 2026-11-12
This study is testing a program that helps older adults in Shanghai get their vision checked and corrected to reduce blindness and visual problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 1000000 (estimated) |
| Sponsor | Shanghai Eye Disease Prevention and Treatment Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | January 1, 2016 |
| Main results expected | November 30, 2019 |
| Study ends | November 30, 2026 |
| Registry record updated | May 24, 2022 |
| Trial ID | NCT03455478 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this program are Shanghai residents aged 18 years and older who are experiencing visual impairment due to refractive errors.
✕Probably not a fit
Patients with cognitive or mobility disorders, as well as those who do not reside in Shanghai or are younger than 18 years old, may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program aims to address blindness and visual impairment among senior citizens in Shanghai, particularly focusing on uncorrected refractive errors. By establishing a public health service mechanism, the initiative will screen and correct refractive errors in the elderly population using a three-level eye disease prevention network. The program will provide spectacles and related services directly to communities to ensure early identification and correction of vision issues. The goal is to significantly reduce the prevalence of blindness and visual impairment in this demographic.
Why it matters
Potential benefit: If successful, this program could greatly enhance the quality of life for elderly patients by improving their vision and reducing the incidence of blindness.
How similar studies have gone: Other studies focusing on refractive error correction in elderly populations have shown positive outcomes, indicating that this approach is supported by previous successes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * shanghai residents aged ≥18 years old Exclusion Criteria: * cognitive and/or mobility disorders; non-shanghai residents; younger than 18 years old.
Where it's running
-
Shanghai Eye Disease Prevention & Treatment Center
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Xun Xu, MD
- Email: drxuxun@tom.com
- Phone: 8613386259538
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted DIMS glasses to stop myopia in young children with pre-myopia
This trial tests whether AI-assisted DIMS-style glasses can help prevent myopia in children aged 3–6 who are at risk.
-
Gabor-based visual training for adults with amblyopia
This study tests a computer-based Gabor training program to see if it can improve vision in adults aged 18–39 with amblyopia due to anisometropia or strabismus.
-
Auricular Acupressure to Help Prevent Myopia in Young Kids With Limited Hyperopic Reserve
This trial tests whether auricular acupressure, added to standard eye health education, can help prevent myopia in elementary students who don’t have enough hyperopic reserve.
-
Myopia control for kids using defocus lenses with ear acupressure in school
This trial tests whether adding auricular acupressure to defocus spectacle lenses can better slow myopia progression in primary school children with premyopia or myopia.
-
Outdoor activity program with wearable support to help prevent myopia in schoolchildren with good hyperopic reserve
A school-based program using a wearable device to promote outdoor activity is tested to see if it can help prevent myopia in kids in grades 1–4 who have adequate hyperopic reserve.
-
Low-level red light to slow retinal thinning in pathologic myopia
This trial will test whether twice-daily low-level red light therapy can slow retinal atrophy in adults with pathologic myopia and is safe to use.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.